SMPD1 and neoplasm: In vivo, systemic treatment with Ad5H2E-PPE1(3x)-ASMase confers ASMase over-expression exclusively in angiogenic endothelium within tumors, enhancing endothelial sensitivity to radiation-induced apoptosis and tumor cure, affording conversion of radiation-incurable tumors into permanent tumor ablation.